Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Phase 1 crawled date : 2021 - 05 - 03 save search
Merus Announces First Patient Treated in Phase 1/2 Clinical Trial of MCLA-129 in Advanced Lung Cancer and Other Solid TumorsMerus’ Fourth Sponsored Bispecific Antibody Currently in Clinical Trials
Published: 2021-05-03 (Crawled : 21:00) - biospace.com/
MRUS | $39.83 -1.58% -1.61% 800K
|
Health Technology
|
| O: -0.29%
H: 9.87%
C: 9.1%
lung cancer solid tumors clinical trials phase 1 cancer antibody trial phase 3
Regulus Therapeutics Announces Top-Line Data from the First Cohort of Phase 1b Clinical Trial of RGLS4326 for the Treatment of Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Published: 2021-05-03 (Crawled : 14:00) - biospace.com/
RGLS | $2.13 -4.05% -4.23% 220K
|
Health Technology
|
| O: -2.16%
H: 2.18%
C: -17.65%
disease treatment phase 1 trial topline phase 1b kidney phase 2b
AGTC Clinical Investigators Provide Encore Presentation of Data from the Company’s Ongoing XLRP and Achromatopsia Phase 1/2 Trials
Published: 2021-05-03 (Crawled : 13:00) - globenewswire.com
AGTC | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 3.66%
H: 0.11%
C: -6.04%
presentation ongoing phase 1 trial phase 3 phase 2
Repare Therapeutics Doses First Patient in Phase 1 Clinical Trial of RP-6306, a First-in-Class, Selective, Oral Inhibitor of PKMYT1
Published: 2021-05-03 (Crawled : 12:00) - biospace.com/
RPTX 4 | $3.14 3.97% 3.82% 220K
|
Health Technology
|
| O: -0.52%
H: 1.75%
C: 0.4%
phase 1 trial phase 3 phase 2
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.